These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

806 related items for PubMed ID: 12939858

  • 1. [Antihypertensive treatment for patients with hypertension and diabetes type II--current clinical research].
    Rajzer M, Kawecka-Jaszcz K, Wojciechowska W.
    Przegl Lek; 2003; 60(2):111-5. PubMed ID: 12939858
    [Abstract] [Full Text] [Related]

  • 2. Effects of renin-angiotensin system inhibition on end-organ protection: can we do better?
    Weir MR.
    Clin Ther; 2007 Sep; 29(9):1803-24. PubMed ID: 18035185
    [Abstract] [Full Text] [Related]

  • 3. Current recommendations for the treatment of hypertension: are they still valid?
    Moser M.
    J Hypertens Suppl; 2002 Feb; 20(1):S3-10. PubMed ID: 11996197
    [Abstract] [Full Text] [Related]

  • 4. Choice of antihypertensive drug in the diabetic patient.
    Ong HT, Cheah JS.
    MedGenMed; 2005 May 04; 7(2):74. PubMed ID: 16369452
    [Abstract] [Full Text] [Related]

  • 5. The 2004 Canadian recommendations for the management of hypertension: Part II--Therapy.
    Khan NA, McAlister FA, Campbell NR, Feldman RD, Rabkin S, Mahon J, Lewanczuk R, Zarnke KB, Hemmelgarn B, Lebel M, Levine M, Herbert C, Canadian Hypertension Education Program.
    Can J Cardiol; 2004 Jan 04; 20(1):41-54. PubMed ID: 14968142
    [Abstract] [Full Text] [Related]

  • 6. ESH-ESC guidelines for the management of hypertension.
    Erdine S, Ari O, Zanchetti A, Cifkova R, Fagard R, Kjeldsen S, Mancia G, Poulter N, Rahn KH, Rodicio JL, Ruilope LM, Staessen J, van Zwieten P, Waeber B, Williams B.
    Herz; 2006 Jun 04; 31(4):331-8. PubMed ID: 16810473
    [Abstract] [Full Text] [Related]

  • 7. The outcome of STOP-Hypertension-2 in relation to the 1999 WHO/ISH hypertension guidelines.
    Lindholm LH.
    Blood Press Suppl; 2000 Jun 04; 2():21-4. PubMed ID: 11055468
    [Abstract] [Full Text] [Related]

  • 8. [Recent intervention studies with antihypertensive drugs and their influence on guidelines].
    Rahn KH.
    Med Klin (Munich); 2003 Dec 15; 98(12):771-5. PubMed ID: 14685679
    [Abstract] [Full Text] [Related]

  • 9. [Are all antihypertensive drugs renoprotective?].
    Wolf S, Risler T.
    Herz; 2004 May 15; 29(3):248-54. PubMed ID: 15167950
    [Abstract] [Full Text] [Related]

  • 10. Long-term safety of antihypertensive therapy.
    Grossman E, Messerli FH.
    Prog Cardiovasc Dis; 2006 May 15; 49(1):16-25. PubMed ID: 16867847
    [Abstract] [Full Text] [Related]

  • 11. ACE inhibitor-based treatment and antihypertensive effects in patients with type 2 diabetes.
    Jarmuzewska EA, Rocchi R, Guidoni A, Mangoni AA.
    Panminerva Med; 2008 Sep 15; 50(3):207-16. PubMed ID: 18927524
    [Abstract] [Full Text] [Related]

  • 12. Exploring the optimal combination therapy in hypertensive patients with diabetes mellitus.
    Reboldi G, Gentile G, Angeli F, Verdecchia P.
    Expert Rev Cardiovasc Ther; 2009 Nov 15; 7(11):1349-61. PubMed ID: 19900018
    [Abstract] [Full Text] [Related]

  • 13. Diabetes and hypertension, the deadly duet: importance, therapeutic strategy, and selection of drug therapy.
    Deedwania PC.
    Cardiol Clin; 2005 May 15; 23(2):139-52. PubMed ID: 15694743
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. [Risk factors to be considered at the beginning of antihypertensive therapy in diabetes mellitus].
    Jermendy G.
    Orv Hetil; 2004 May 02; 145(18):949-56. PubMed ID: 15188641
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Treatment of hypertension in chronic kidney disease.
    Toto RD.
    Semin Nephrol; 2005 Nov 02; 25(6):435-9. PubMed ID: 16298269
    [Abstract] [Full Text] [Related]

  • 18. RAS inhibition in hypertension.
    Ibrahim MM.
    J Hum Hypertens; 2006 Feb 02; 20(2):101-8. PubMed ID: 16397519
    [Abstract] [Full Text] [Related]

  • 19. [The role of angiotensin II AT1-receptor antagonists in renal and cardiac protection in type-2 diabetes mellitus].
    Ravera M, Deferrari L, Ratto E, Vettoretti S, Parodi D, Deferrari G.
    Ital Heart J Suppl; 2003 Mar 02; 4(3):210-6. PubMed ID: 12784755
    [Abstract] [Full Text] [Related]

  • 20. [Reasons for not intensifying antihypertensive treatment to diabetes in some regions of China].
    Guo QH, Pan CY, Qi WH, Lin SY, ARB Scientifc and Clinical Collaboration, China.
    Zhonghua Yi Xue Za Zhi; 2008 Jan 22; 88(4):240-4. PubMed ID: 18361834
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 41.